Solution: slash the prices and kill the ads. (Common Dreams) Prescription drugs have long provided two bad examples of American exceptionalism. They cost three-to-four times more than anywhere else, and we’re one of only two countries in the ...
To make matter worse, Remdesivir is a drug that “has had its development costs paid for, in large part, by independent donors like governments and ministries of health in China, the WHO, and the US government.” ...
“There’s no doubt that the prospect of an enormous public backlash is what made the difference.” (By: Julia Conley, Common Dreams) Government watchdog Public Citizen celebrated Wednesday afternoon as pharmaceutical giant Gilead Sciences backed off ...
“The industry executive said the quiet part out loud,” said one outside expert in response. “Price-gouging is central to the industry business model.” (By: Andrea Germanos, Common Dreams) Corporations’ quest for profits is what “is ...
“Under the new paradigm of private equity, poorly maintained ambulance services siphon profit from vulnerable patients.” Wall Street investment firms are behind soaring ambulance costs, according to a Thursday article by the American Prospect’s Olivia ...
“This is most likely the largest cartel in the history of the United States.” The Connecticut Attorney General’s office is heading an explosive investigation into coordinated drug price-fixing among at least 16 generic drug manufacturers ...
Nirmal Mulye, founder and president of Nostrum Pharmaceuticals, is quoted in a Financial Times article on Tuesday saying that he has a moral requirement to sell the product at the highest price. Mulye told Financial ...
“This is a Shkreliesque move, and is near to first degree murder as one can get without risking jail,” said one critic, referencing the Big Pharma CEO that infamously raised the price of an AIDS ...